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Abstract
Introduction—Favorable cardiovascular health (FCH) is associated with healthy longevity and 
reduced cardiovascular mortality risk. However, limited work has investigated the distribution of 
FCH in older age or considered the antecedents of FCH. Based on prior work linking 
psychological well-being with cardiovascular endpoints, higher psychological well-being was 
hypothesized to be associated with increased likelihood of maintaining FCH over time.
Methods—Data were from the English Longitudinal Study of Ageing. The first study wave 
(2002–2003) included men and women aged ≥50 years. The analytic sample (N=4,925) was 
restricted to individuals without baseline cardiovascular disease and with clinical data from three 
follow-ups through 2013. Psychological well-being was assessed with 17 items from the Control, 
Autonomy, Satisfaction, and Pleasure scale. FCH was defined as being a non-smoker, diabetes-
free, and having healthy levels of blood pressure, cholesterol, and BMI (FCH scores ranged from 
0–5). Statistical analyses conducted in 2016–2017 used linear mixed models to examine 
associations between psychological well-being and FCH scores over time. Secondary analyses 
examined cardiovascular-related mortality.
Results—Only 1% of participants achieved complete FCH at study baseline. Adjusting for 
sociodemographic factors and depression, greater psychological well-being was associated with 
higher FCH scores across time (β=0.05, 95% CI=0.02, 0.08), but not rate of change in FCH. 
Psychological well-being was also associated with a 29% reduced risk of cardiovascular-related 
mortality in multivariable-adjusted models.
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Conclusions—Findings suggest that psychological well-being is associated with having FCH at 
older ages, and add to knowledge of assets that may increase likelihood of healthy aging.
INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death worldwide and the burden of 
disease is high, especially among adults aged >50 years.1 To delay the onset and progression 
of CVD, traditional prevention strategies are often used to mitigate risk factors. However, 
reducing damage imposed by risk factors is neither the same nor as desirable as maintaining 
health across the lifespan. In fact, once risk factors are established, the probability of 
experiencing CVD is dramatically increased and medication does not fully restore low risk.2 
By contrast, adults who are able to maintain favorable cardiovascular health (FCH), defined 
by healthy levels of blood pressure and lipids, healthy body weight, being diabetes-free, and 
avoiding cigarette smoking,3,4 show dramatically reduced risk for CVD and premature 
death.3–5 Thus, primordial prevention—that is, preventing adverse levels of risk factors from 
becoming established—may be an effective strategy for fostering cardiovascular health 
across the lifespan.6
However, it remains unclear how many adults achieve FCH and then maintain it. Based on 
current estimates, prevalence appears surprisingly low. In one study of women aged 18–39 
years, 20% met criteria for having FCH.3 In another study of over 350,000 men and women 
aged 18–60 years, only 5%–10% were non-smokers with healthy levels of blood pressure 
and cholesterol.5 Another metric called ideal cardiovascular health has been defined as 
meeting recommended levels of physical activity and healthy diet in addition to the other 
factors used to define FCH. Prevalence of ideal cardiovascular health is even lower, with 
estimated prevalence of <1% in older adults.7–9
Factors that enable individuals to maintain FCH in older age are largely unidentified, 
although research suggests that psychological factors during childhood may be relevant.10,11 
Psychological attributes may be prime candidates because they shape how individuals 
perceive, interact with, and behave in the world, but are also modifiable by the social 
environment.12 Researchers have long recognized links between psychological health and 
CVD, but most focus on how poor psychological functioning (e.g., depression) increases 
disease risk.13,14 Recent evidence suggests psychological well-being—such as having a 
sense of purpose and a positive outlook—may reduce disease risk independently of 
depression or other indicators of psychological distress.15 For example, prospective studies 
demonstrate that experiencing satisfaction with life, optimism, and positive feelings are 
associated with reduced risk of heart attack, stroke, and cardiovascular death.16–18 Given 
these established links with CVD, psychological well-being (hereafter called well-being) 
may also be associated with an actively healthy profile as characterized by maintaining FCH 
across time.
Using a primordial prevention framework with data from the English Longitudinal Study of 
Ageing (ELSA), the prevalence of FCH in older adults and whether well-being predicts FCH 
is investigated. Low prevalence of FCH is expected. Individuals with higher versus lower 
well-being levels are expected to have higher FCH scores and show slower declines in FCH 
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as they age. Associations are further hypothesized to be independent of sociodemographic 
characteristics and depression status, potential confounders identified from prior work.15 In 
secondary analyses, well-being’s association with cardiovascular-related mortality is 
examined. Sensitivity analyses test the possibility of reverse causality between FCH and 
well-being, and well-being’s relationship with the components of FCH.
METHODS
Study Population
Data were from ELSA, a nationally representative cohort study of the community-dwelling 
English population aged ≥50 years. ELSA participants were recruited from households that 
participated in the Health Survey for England (an annual national cross-sectional health 
survey) in 1998, 1999, and 2001.19 All Health Survey for England households that contained 
at least one person aged ≥50 years who consented to be re-contacted were eligible for 
ELSA.
The first ELSA interview (Wave 1) in 2002–2003 included 11,391 men and women.19 
Follow-up interviews with the original cohort members occurred in 2004–2005 (Wave 2), 
2006–2007 (Wave 3), 2008–2009 (Wave 4), 2010–2011 (Wave 5), and 2012–2013 (Wave 6); 
response rates ranged from 73%–82% across waves.19 Clinical health examinations were 
performed in conjunction with interviews during Waves 2, 4, and 6; thus, measures of FCH 
were available only at these waves with Wave 2 serving as the present study’s baseline.
At Wave 2, there were 8,780 core ELSA members who participated in the main interview. 
Excluding individuals with baseline CVD (n=1,563; i.e., self-reported doctor-diagnosed 
angina, heart attack, congestive heart failure, or stroke), missing information on well-being 
or covariates (n=937), and without at least one FCH measure (n=1,355) resulted in an 
analytic sample of 4,925 participants (Figure 1). Excluded versus included participants 
tended to be older, more likely to be men and non-white, have lower levels of education, 
earn less income, and have lower baseline well-being.
This study complies with the Declaration of Helsinki. ELSA has been approved by various 
ethics committees, including the London Multicentre Research Ethics Committee. All 
participants provided informed consent.
Measures
Well-being was assessed with items from the 19-item Control, Autonomy, Satisfaction, 
Pleasure (CASP-19) scale during each wave of ELSA. The CASP-19 assesses psychological 
functioning in older adults and was originally generated and validated in the United 
Kingdom with 264 people of “early old age” (aged 65–75 years).20 It is a summative scale 
covering four domains: control, autonomy, pleasure, and self-realization. Each item is scored 
on a 4-point scale describing how much each statement applies; higher scores represent 
greater well-being. The CASP-19 has demonstrated good internal consistency and construct 
validity in ELSA and other samples.20,21
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To prevent physical health from confounding the association between well-being and FCH, 
two items related to health were removed (My age prevents me from doing the things I 
would like to and My health stops me from doing things I want to do). Internal consistency 
reliability was good for this 17-item scale (α=0.87). The CASP-17 from Wave 2 was used in 
analyses to correspond with the wave in which FCH was first assessed. If participants 
completed at least nine of the 17 items, then missing values were imputed with the mean 
value of non-missing items (only 275 individuals [5.58%] required imputed CASP-17 
values; most [n=197] were missing only a single item). Analyses considered CASP-17 as 
either a continuous (mean=39.60, SD=7.26, range, 0–51) or categorical variable. The latter 
used tertiles based on the analytic sample’s distribution of scores to assess the possibility of 
discontinuous effects (low: <38; moderate: 38 to <44; high: ≥44).
Consistent with past work, FCH was defined by five components: (1) No self-reported 
doctor diagnosis of high blood pressure, systolic blood pressure ≤120 mm Hg, and diastolic 
blood pressure ≤80 mm Hg; (2) No self-reported doctor diagnosis of high cholesterol and 
total cholesterol <200 mg/dL; (3) BMI <25 kg/m2; (4) No self-reported doctor diagnosis of 
diabetes (fasting glucose was assessed, but many participants were missing that information 
so it was not included in the FCH criteria); and (5) Non-smoker (either never or formerly 
smoked cigarettes).3 A total FCH score was created at each wave (ranging from 0 to 5) by 
totaling the number of healthy components maintained by individuals. Although this FCH 
score weighs each component equally, this straightforward approach is useful when tracking 
cardiovascular health over time (versus developing a clinical risk score).22 Moreover, 
considering cardiovascular health in aggregate may improve predictions based on any single 
component.4 If participants developed CVD during a follow-up wave, they were assigned a 
FCH score of 0 for that wave and subsequent waves. Medication use for high blood pressure, 
high cholesterol, and diabetes is often included as part of the FCH score. However, ELSA 
participants answered questions about medication use only if they indicated being diagnosed 
with the condition. For this reason, medication use provided nearly identical information to 
diagnosis and was not included in the FCH score. Another definition of cardiovascular 
health has been proposed that takes diet and physical activity into account23; however, 
because those health behaviors may be a pathway linking well-being to cardiovascular 
outcomes,15 they were not included.
Nurses clinically assessed blood pressure, cholesterol (fasting when possible), height, and 
weight during examinations at Waves 2, 4, and 6. Blood samples were analyzed in the Royal 
Victoria Infirmary.24 The average time between nurse examinations was 3.91 years 
(SD=0.57) for Waves 2 and 4, and 3.79 years (SD=0.49) for Waves 4 and 6. Information on 
self-reported doctor-diagnosed cardiovascular conditions (high blood pressure, high 
cholesterol, and diabetes) and cigarette smoking status (current smoker, former smoker, or 
never smoker) was assessed during interviews.
Baseline covariates were self-reported at Wave 2. Age was measured continuously in years, 
with participants aged >90 years assigned the value of 91 to preserve confidentiality. Gender 
was categorized as men or women; race was categorized as white or non-white. SES was 
assessed by educational attainment (university degree or equivalent, higher education but not 
university degree, A-level [national school exam at age 18 years, high school equivalent], O-
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level [national school exam at age 16 years], or less than O-level) and total weekly income 
(measured continuously). Participants also self-reported doctor-diagnosed depression status 
(depressed, non-depressed).
Statistical Analysis
SAS, version 9.4, was used to conduct analyses during 2016–2017 (p<0.05 significance 
level, two-tailed). Distributions of baseline (Wave 2) characteristics and FCH scores across 
baseline tertiles of well-being were examined. Next, the prevalence of FCH at each wave and 
the extent to which FCH scores changed over follow-up was examined. Primary analyses 
used linear mixed models to evaluate associations between Wave 2 well-being and FCH 
scores across time. Well-being was examined as either a continuous (standardized) or 
categorical (tertiled) variable. A set of models was fit adjusted first for age, gender, and race; 
second, SES (education and income) was added; third, depression diagnosis was added. 
Given healthier individuals may be more likely to undergo exams at subsequent waves, these 
models also accounted for attrition by weighting with a revisit propensity score. This score 
was calculated from a logistic regression as the probability of having two or three exams 
given all relevant factors at baseline including age, gender, race, education, income, and 
depression diagnosis. Using this score, inverse probabilities of multiple exams were created 
and members of the analytic sample were weighted to account for bias because of missing 
data.25 To assess consistency of health-related effects of CASP-17 as compared with other 
indicators of well-being that have been used previously,18 secondary analyses used logistic 
regression to determine if CASP-17 was related to reduced risk of cardiovascular-related 
death, among individuals free from baseline CVD and with complete data regarding well-
being, covariates, and death (N=5,944). Sensitivity analyses considered potential for reverse 
causality by testing whether Wave 2 FCH scores predicted well-being levels through Wave 
6, as well as well-being’s relationship with individual components of FCH in logistic 
regression.
RESULTS
Participants were on average aged 64.6 years (SD=8.7 years, range, 52–91 years), with 2,139 
men and 2,786 women (56.6%); most were white (98.9%). Individuals with higher well-
being levels at Wave 2 were more likely to be white, be more highly educated, earn higher 
incomes, and less likely to be depressed (Table 1). Baseline well-being was also associated 
with higher FCH scores at each assessment (rWave2 =0.05, rWave4 =0.09, rWave6 =0.05, all 
ps<0.01). Trajectories of FCH scores across time for each well-being tertile are shown in 
Appendix Figure 1.
Approximately 1% of participants achieved FCH in each wave (i.e., healthy status on all 
components; Appendix Table 1). The vast majority of participants were healthy on only two 
(45%–52%) or three components (26%–30%) at any given wave. Moreover, most 
participants showed no change in FCH scores across time (Appendix Table 2). Indeed, 56% 
of participants had the same level of FCH at Waves 2 and 6.
Linear mixed models examined baseline well-being’s association with FCH scores across 
time and initially included an interaction term for well-being X time. However, the 
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interaction was not statistically significant in any model, indicating well-being was not 
related to rate of change in FCH across time. As a result, the interaction term was removed 
from models reported here. These show higher well-being levels were consistently 
associated with higher FCH scores over time (Table 2). This association held in minimally 
adjusted models and when adjusting for SES and depression. Similar findings were evident 
with well-being tertiles. For example, in the multivariable-adjusted model, both moderate 
(β=0.11, 95% CI=0.04, 0.17, p<0.05) and high (β=0.09, 95% CI=0.02, 0.15, p<0.05) well-
being levels were positively associated with FCH scores across time (but well-being level 
did not interact significantly with time to predict FCH).
Secondary analyses examined whether baseline well-being was associated with 
cardiovascular-related mortality. During approximately 8 years of follow-up, 162 
cardiovascular-related deaths (2.73%) occurred. Consistent with findings regarding FCH, a 
one SD higher baseline well-being level was associated with nearly 30% lower 
multivariable-adjusted odds of dying from CVD (Table 3). The pattern was similar when 
considering well-being tertiles. Individuals in the highest versus lowest well-being tertile 
had up to 35% lower multivariable-adjusted odds of cardiovascular death (OR=0.65, 95% 
CI=0.43, 0.99). Similar associations were evident for moderate well-being levels (OR=0.56, 
95% CI=0.37, 0.84).
Sensitivity analyses evaluated whether total FCH score at Wave 2 predicted well-being in 
subsequent waves (through Wave 6). In all models, Wave 2 FCH score was positively 
associated with well-being at each time point (β=0.54, 95% CI=0.29, 0.79, p<0.05). Time 
was significantly associated with declines in well-being (p<0.05). However, the interaction 
between FCH score X time was not statistically significant, suggesting effects of time on 
rate of change in well-being did not depend on initial FCH. Moreover, baseline well-being 
was individually associated with healthier diabetes status, smoking status, and blood 
pressure, but not cholesterol and BMI (Appendix Table 3).
DISCUSSION
Although FCH is associated with healthier aging and reduced risk of CVD, limited research 
has examined its distribution in older age and psychosocial antecedents. This study 
investigated the prevalence of FCH and whether well-being was associated with the presence 
and maintenance of FCH across approximately 8 years in older adults. Consistent with past 
findings,5 few people achieved or maintained FCH in older adulthood. Furthermore, 
cardiovascular health remained relatively stable during older age such that there was limited 
change in FCH scores. Changes that occurred were primarily characterized by declines in 
FCH rather than improvements. Nonetheless, as expected, men and women with higher 
baseline levels of well-being were more likely to have healthier FCH levels across all time 
points, adjusting for sociodemographic characteristics and depression. However, well-being 
was not related to rate of change in FCH, perhaps because there was relatively little change 
occurring. In line with prior work18 and providing further support for the notion that well-
being is associated with better cardiovascular health, individuals with greater initial well-
being were also less likely to die from cardiovascular-related mortality during follow-up.
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Past studies have considered how psychosocial factors in childhood relate to FCH in 
adulthood,10 but this is the first study to prospectively investigate adult psychosocial factors 
in relation to attaining and maintaining cardiovascular health in old age. No other 
longitudinal studies have examined well-being in relation to FCH. One previous study 
reported associations between optimism and ideal cardiovascular health, but the cross-
sectional design limited conclusions about the direction of the relationship.26 However, the 
current study is the only one that investigates how psychosocial factors in older adulthood 
might contribute to achieving and maintaining FCH over time.
The sizes of associations in this study were modest, but even small effect sizes can have 
important implications at the population level, especially if effects compound or accumulate 
over time.27–29 Although the relationship between well-being and health is likely 
bidirectional, most research has investigated whether health leads to changes in 
psychological states rather than the reverse. However, evidence suggests well-being may 
precede important health outcomes and that it can be enhanced through intervention.30 
Preliminary studies also demonstrate that well-being interventions are feasible in at-risk 
populations and promote physical as well as psychological health.31 If well-being can be 
shown to contribute causally to achieving FCH, then it may serve as a target for intervention 
with the goal of improving lifetime ability to attain and maintain cardiovascular health.32
One theoretical model posits that well-being relates to healthy cardiovascular functioning 
not only by buffering the cardiotoxic effects of stress, but also by enhancing biological and 
behavioral functioning.15 Although biological and behavioral pathways were not tested 
because of limited follow-up, such analyses would be useful in future studies. Unlike other 
markers of cardiovascular health,23 the FCH metric has the advantage of keeping the 
potential mediating factors of physical activity and diet separate from the definition of 
cardiovascular health.
Limitations
Study limitations include self-reported data and a homogeneous sample of white English 
adults aged >50 years. Without additional diversity, conclusions cannot be broadly 
generalized. Moreover, individuals included versus excluded from the analytic sample 
tended to be younger, more socioeconomically advantaged, and healthier. Well-being and 
FCH later in life were considered, which is a time when behavioral and other tendencies are 
well-established. This may result in conservative tests of the hypotheses because relatively 
few people in the ELSA cohort made it to older age with complete FCH. It may be 
informative to assess well-being in younger cohorts when both the prevalence of FCH may 
be higher and interventions to improve cardiovascular health may be more effective because 
psychological and behavioral factors are not as well entrenched. Finally, because of how 
medication use was assessed in ELSA, analyses could not thoroughly account for it.
Study strengths include a prospective design that not only excluded people with pre-existing 
CVD, but also examined cardiovascular-related mortality as a secondary outcome. 
Additionally, the possibility of reverse causality was evaluated and potential confounders 
were controlled. Notably, adding depression status to the models did not alter conclusions, 
suggesting that well-being’s effects are more than the mere absence of depression.
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CONCLUSIONS
Current findings build upon past work indicating that well-being is associated with reduced 
CVD risk.15 Beyond reducing risk for disease, this study illustrates that well-being is also 
associated with maintaining healthier cardiovascular functioning. These findings contribute 
to a more comprehensive definition of what it means to enjoy cardiovascular health and 
highlight psychological factors that may be important for healthy aging.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Sample size flow chart.19
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Table 1
Distribution of Participant Characteristics by Tertiles of Well-being
Variable Low
CASP-17
Scores <38 (N=1,633)
n (%)
Moderate
CASP-17
Scores 38–<44 (N=1,622)
n (%)
High
CASP-17
Scores ≥44 (N=1,670)
n (%)
p-value
Mean age (years) at Wave 2 (SD) 64.70 (9.21) 64.6 (8.68) 64.4 (8.19) 0.51
Gender 0.27
 Men 734 (45.0) 700 (43.2) 705 (42.2)
 Women 899 (55.1) 922 (56.8) 965 (57.8)
Race 0.01
 White 1,604 (98.2) 1,607 (99.1) 1,658 (99.3)
 Non-white 29 (1.78) 15 (0.92) 12 (0.72)
Education at Wave 2 <0.0001
 University degree 165 (10.1) 234 (14.4) 297 (17.8)
 Higher education, no degree 189 (11.6) 211 (13.0) 246 (14.7)
 A-level 114 (6.98) 114 (7.03) 122 (7.31)
 O-level 297 (18.2) 337 (20.8) 331 (19.8)
 Less than O-level 868 (53.2) 726 (44.8) 674 (40.4)
Mean weekly income at Wave 2 (SD) 249.6 (169.6) 302.8 (223.4) 345.5 (292.8) <0.0001
Depression status at Wave 2 <0.0001
 Depressed 194 (11.9) 94 (5.8) 56 (3.35)
 Non-depressed 1,439 (88.1) 1,528 (94.2) 1,614 (96.7)
Mean total FCH score at Wave 2 (SD) 2.38 (0.83) 2.48 (0.84) 2.48 (0.79) 0.002
Mean total FCH score at Wave 4 (SD) 2.12 (1.06) 2.30 (1.03) 2.30 (0.96) <0.0001
Mean total FCH score at Wave 6 (SD) 2.02 (1.13) 2.19 (1.11) 2.14 (1.07) 0.004
Notes: N=4,925. Percentages refer to the proportion of individuals within each well-being tertile with that characteristic. p-value comes from chi-
square or ANOVA. Boldface indicates statistical significance (p<0.05).
CASP-17, 17-item Control, Autonomy, Satisfaction, Pleasure scale; FCH, favorable cardiovascular health
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Table 2
Relationship Between Wave 2 Well-being and FCH Scores From Waves 2, 4, and 6
Variable
β (95% CI)
Model 1a Model 2b Model 3c
Well-being (standardized) at Wave 2 0.07 (0.05, 0.10) 0.05 (0.03, 0.08) 0.05 (0.02, 0.08)
Time −0.04 (−0.05, −0.04) −0.04 (−0.05, −0.04) −0.04 (−0.05, −0.04)
Age at Wave 2 −0.01 (−0.01, −0.01) −0.005 (−0.01, −0.002) −0.005 (−0.01, −0.002)
Gender (women as reference) −0.04 (−0.08, 0.01) −0.07 (−0.12, −0.02) −0.07 (−0.12, −0.02)
Race (whites as reference) 0.15 (−0.08, 0.38) 0.15 (−0.08, 0.38) 0.15 (−0.08, 0.37)
Education (less than O-level as reference) at Wave 2
 University degree 0.23 (0.15, 0.31) 0.23 (0.15, 0.31)
 Higher education, not university degree 0.10 (0.02, 0.17) 0.10 (0.02, 0.17)
 A-level 0.15 (0.05, 0.24) 0.15 (0.05, 0.25)
 O-level 0.15 (0.09, 0.22) 0.15 (0.09, 0.22)
Income at Wave 2 0.07 (0.04, 0.10) 0.07 (0.03, 0.10)
Depression status (non-depressed as reference) at Wave 2 −0.03 (−0.13, 0.07)
Notes: N=4,925. Boldface indicates statistical significance (p<0.05).
a
Linear mixed models adjusted for age, gender, and race.
b
Linear mixed models adjusted for Model 1 characteristics and SES (education, income).
c
Linear mixed models adjusted for Model 2 characteristics and depression status.
FCH, favorable cardiovascular health
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Table 3
Association Between Wave 2 Well-being and Cardiovascular-related Mortality in Individuals Without Baseline 
CVD
Variable
OR (95% CI)
Model 1 Model 2 Model 3
Well-being (standardized) at Wave 2 0.72 (0.61, 0.85) 0.73 (0.61, 0.87) 0.71 (0.59, 0.84)
Age at Wave 2 1.15 (1.13, 1.18) 1.15 (1.13, 1.17) 1.15 (1.13, 1.17)
Gender (women as reference) 1.73 (1.25, 2.42) 1.80 (1.28, 2.53) 1.80 (1.28, 2.52)
Race (whites as reference) 0.91 (0.12, 7.16) 1.05 (0.15, 7.58) 1.05 (0.15, 7.37)
Education (less than O-level as reference) at Wave 2
 University degree 0.42 (0.19, 0.94) 0.43 (0.19, 0.97)
 Higher education, not university degree 1.47 (0.90, 2.43) 1.47 (0.90, 2.42)
 A-level 0.90 (0.45, 1.81) 0.89 (0.44, 1.80)
 O-level 0.68 (0.39, 1.18) 0.68 (0.39, 1.18)
Income at Wave 2 1.05 (0.97, 1.14) 1.05 (0.97, 1.14)
Depression status (non-depressed as reference) at Wave 2 0.40 (0.12, 1.37)
Notes: N=5,944. 162 deaths. Boldface indicates statistical significance (p<0.05).
a
Logistic regression models adjusted for age, gender, and race.
b
Logistic regression models adjusted for Model 1 characteristics and SES (education, income).
c
Logistic regression models adjusted for Model 2 characteristics and depression status.
CVD, cardiovascular disease
Am J Prev Med. Author manuscript; available in PMC 2018 December 01.
